Cannabis extractor Nextleaf Solutions has been granted its second US patent for the acetylation of cannabinoids. The patent covers a process for acetylating CBD and the subsequent extraction of CBO-O-Acetate. In February, the Vancouver-based company obtained a patent...
Consumer demand has been pushing the THC potency of herbal cannabis upward for decades, but does that increased potency extend to cannabis resin, and to CBD levels, as well? A new report has answers.
How hot is just hot enough? As with so much else involving cannabis, it’s a challenging balance.
Join our Science Symposium, part of MJBizCon 2020, on Nov. 24, 2020 for more on genetics and production science. Despite the generally poor economic environment and the tight financing facing cannabis businesses, two cannabis innovation projects based in Canada have...
While there is significant evidence cannabis can be used to treat chronic pain, a new study suggests it might not be useful for other types of pain and may, in fact, cause harm. Unpublished research presented at the Anesthesiology 2020 annual meeting shows prior...
We know cannabis use affects sleep. While it has been used for centuries to improve sleep, there is more recent evidence it can also interfere with sleep depending on the amount used. But why? A published study in the journal Sleep sheds some light on this connection...
A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64% increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often prescribed to treat symptoms associated with COPD, including pain, sleep difficulties and breathlessness.
Following up on encouraging news in August from Willow Biosciences about its large production runs of biosynthetic cannabigerol (CBG), another biotechnology company has announced the first sale of CBD produced using a similar fermentation process. Hyasynth, based in...
Recent recommendations by the Surgeon General of the United States that clinicians and dispensaries discourage pregnant women from using cannabis received support from a new report published in JAMA Psychiatry.
Contributing to a growing list of synthetically produced cannabis compounds, Sanobiotec announced the synthesis of pure and stable Tetrahydrocannabivarin (THCV).
Marijuana Business Daily announced it is canceling its in-person flagship conference, MJBizCon, for 2020 because of the coronavirus pandemic and will instead offer a five-week digital conference and trade show starting Nov. 2 and culminating with the main event Dec. 2-4.
One of hundreds of cannabinoids, cannabichromenic acid (CBCA) may hold an important key to combatting methicillin-resistant Staphylococcus aureus (MRSA), the superbug that kills at least 9,000 people in the US each year and has left healthcare providers scrambling for...
